DMTF1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 3.819600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
2.936400E-01
Normal-vs-Stage2
3.784000E-01
Normal-vs-Stage3
2.325000E-01
Normal-vs-Stage4
4.373600E-01
Stage1-vs-Stage2
4.956200E-01
Stage1-vs-Stage3
7.609700E-02
Stage1-vs-Stage4
9.278600E-01
Stage2-vs-Stage3
1.411990E-01
Stage2-vs-Stage4
4.977400E-01
Stage3-vs-Stage4
1.338640E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
3.858800E-01
Normal-vs-AfricanAmerican
1.645990E-01
Normal-vs-Asian
1.594640E-01
Caucasian-vs-AfricanAmerican
7.275600E-01
Caucasian-vs-Asian
8.288800E-01
AfricanAmerican-vs-Asian
9.018200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
3.830600E-01
Normal-vs-Female
3.843600E-01
Male-vs-Female
9.771600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
6.144800E-01
Normal-vs-Age(41-60Yrs)
4.819000E-01
Normal-vs-Age(61-80Yrs)
3.470400E-01
Normal-vs-Age(81-100Yrs)
2.974000E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
6.047600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
1.853770E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
5.018400E-02
Age(41-60Yrs)-vs-Age(61-80Yrs)
7.040300E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
3.040000E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
4.199600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
3.473200E-01
Normal-vs-Daily Drinker
1.039780E-01
Normal-vs-Weekly Drinker
1.404010E-01
Normal-vs-Occasional Drinker
9.197800E-02
Normal-vs-Social Drinker
4.882400E-01
Non Drinker-vs-Daily Drinker
8.082800E-01
Non Drinker-vs-Weekly Drinker
6.285000E-01
Non Drinker-vs-Occasional Drinker
4.415000E-01
Non Drinker-vs-Social Drinker
8.526400E-02
Daily Drinker-vs-Weekly Drinker
8.601200E-01
Daily Drinker-vs-Occasional Drinker
7.234000E-01
Daily Drinker-vs-Social Drinker
3.139400E-01
Weekly Drinker-vs-Occasional Drinker
8.874800E-01
Weekly Drinker-vs-Social Drinker
4.284800E-01
Occasional Drinker-vs-Social Drinker
4.443400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
2.381400E-01
Normal-vs-Grade 2
4.177700E-02
Normal-vs-Grade 3
1.062560E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
3.106000E-01
Grade 1-vs-Grade 3
6.757600E-01
Grade 1-vs-Grade 4
2.381400E-01
Grade 2-vs-Grade 3
3.233000E-01
Grade 2-vs-Grade 4
4.177700E-02
Grade 3-vs-Grade 4
1.062560E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
3.278000E-01
Normal-vs-NonDiabetic
3.979200E-01
Diabetic-vs-NonDiabetic
1.409420E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
3.935600E-01
Normal-vs-NoPancreatitis
3.661600E-01
Pancreatitis-vs-NoPancreatitis
7.698400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
3.859800E-01
Normal-vs-N1
3.737200E-01
N0-vs-N1
8.142000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
3.844200E-01
Normal-vs-TP53-NonMutant
4.373000E-01
TP53-Mutant-vs-TP53-NonMutant
4.187000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
